BioTech 365

AUGUST 26, 2021

Sorrento Reports Promising Results With mRNA Vaccine For COVID-19 Delivered With The MuVaxx Lymphatic Drug Delivery Device Sorrento Reports Promising Results With mRNA Vaccine For COVID-19 Delivered With The MuVaxx Lymphatic Drug Delivery Device Sorrento’s mRNA vaccine (“STI-mRNA”) delivered with … Continue reading →

Drug Delivery 40

Drug Delivery Vaccination Vaccine Drugs 40

Pharmaceutical Technology

NOVEMBER 15, 2022

When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with safe delivery. By having the drug already dosed inside the chamber and no need to draw it from a vial into a syringe, the process is streamlined and the risk of a potential dosing error is eliminated.

Packaging 130

Packaging Packaging Vaccination Vaccine 130

Roots Analysis

OCTOBER 2, 2023

Owing to their unique size and physicochemical properties ( surface roughness, surface area, surface energy, crystal structure and shape ), nanoparticles can be widely used as a contrasting agent in medical imaging, a vesicle to cross the blood-brain barrier and a carrier for targeted delivery of genes / drugs, proteins, vaccines and antibiotics.

Drug Delivery 40

Drug Delivery Drugs Bioavailability Marketing 40

pharmaphorum

OCTOBER 11, 2022

An intranasal formulation of AstraZeneca’s widely-used COVID-19 vaccine Vaxzevria has failed at the first hurdle, after results from a phase 1 trial found it was unable to stimulate a strong immune response to the virus. Other efforts to develop a nasally-delivered COVID-19 vaccine have met with greater success.

Vaccination 116

Vaccination Vaccine Immune Response Development 116

Drug Discovery World

JANUARY 16, 2024

A new study will compare whether giving tuberculosis vaccine by inhalation is better at protecting against tuberculosis (TB) than injection into the skin. The Jenner Institute at the University of Oxford is conducting the study using Bacille Calmette-Guérin (BCG), the current licensed vaccine against TB.

Clinical Trials 59

Clinical Trials Clinical Trials Vaccination Vaccine 59

XTalks

NOVEMBER 3, 2021

In this episode, Ayesha discusses the FDA’s authorization of Pfizer/BioNTech’s COVID-19 vaccine for children between five and 11 years of age. The editorial team discussed the positive trial data, the importance of vaccinating kids amid rising infections among younger children, as well as vaccine hesitancy among parents.

Life Science 52

Life Science Drug Delivery Systems Vaccination Vaccine 52

pharmaphorum

JUNE 30, 2021

Just a few months after starting clinical trials of its nasal spray vaccine for COVID-19, US biotech Altimmune is abandoning the project, saying that it generated weaker than expected immune responses in a phase 1 trial. . The post Altimmune ditches nasal COVID vaccine on weak trial data appeared first on.

Vaccination 98

Vaccination Vaccine Trials Immune Response 98

Pharmaceutical Technology

NOVEMBER 21, 2022

This will aid in the production of new raw materials and possible clinical-grade assets to develop mRNA vaccines and therapies for infectious diseases, as well as other ailments with unmet needs. RVAC is currently developing mRNA-based vaccines against infectious diseases such as Covid-19.

Manufacturing 130

Manufacturing Medicine Vaccination Vaccine 130

Scienmag

OCTOBER 15, 2020

Entos Pharmaceuticals announces launch of US-based spinout company Aegis Life, Inc.

Vaccination 52

Vaccination Vaccine Drug Delivery Medicine 52

pharmaphorum

MARCH 17, 2022

Alnylam claims it is owed a slice of the massive revenues booked by Pfizer and Moderna for their mRNA-based COVID-19 vaccines, because they are both infringing patents its holds on a delivery technology. The post Alnylam sues Pfizer, Moderna over COVID-19 vaccines appeared first on.

Vaccination 52

Vaccination Vaccine Sales Immune Response 52

BioTech 365

OCTOBER 22, 2020

Synairgen’s SNG001 among the many potential treatments and vaccines to be delivered via Aerogen’s aerosol drug delivery system Adds to the thousands of COVID-19 patients already safely and effectively treated with Aerogen’s Solo aerosol drug delivery system in the intensive … Continue reading →

Drug Delivery Systems 52

Drug Delivery Systems Drug Delivery Development Vaccination 52

Drug Discovery World

JUNE 7, 2023

The additional investment will support growth of the company’s proprietary RALA platform with an immediate focus on the advancement of pHion’s lead project, PTX_V1, into clinical trials in the first half of 2024. PTX_V1 is a first-in-class therapeutic vaccine for the treatment of human papilloma virus (HPV)-related cancers.

Vaccination 52

Vaccination Vaccine Drug Delivery Systems Drug Delivery 52

Roots Analysis

MARCH 21, 2022

However, several drug delivery devices that enable patients to self-administer their respective medications are now available. Subcutaneous drug delivery systems – the helping hand for patients. The emergence of safer and patient-friendly devices is acting as a strong enabler for subcutaneous delivery of therapeutics.

Drug Delivery Systems 52

Drug Delivery Systems Drug Delivery Antibody Marketing 52

Drug Discovery World

JULY 11, 2022

Klaus Cichutek, President of the Paul-Ehrlich-Institute who spoke about fighting the Covid-19 pandemic and Proessor Heinrich Haas, Vice President Formulation and Drug Delivery at BioNTech SE who spoke on the topic of nanotechnologies in the development of vaccines against cancer.

Genome 52

Genome Genomics Drug Delivery Vaccination 52

pharmaphorum

APRIL 28, 2022

Harness Safe & Efficacious Lipid-Based Delivery for Novel Therapeutics Beyond RNA & Hepatic Tissue. The recent success of the mRNA-LNP vaccines fueled biopharma to explore lipid-based nanoparticles for advanced drug delivery.

RNA 52

RNA Drug Delivery Engineer Gene Therapy 52

pharmaphorum

FEBRUARY 28, 2022

As part of SMi’s leading series of drug delivery device conferences, the 2022 event will provide insights into the rapidly accelerating market of combination product development with industry, device developer and regulatory perspectives. Uncover the key considerations to ensure optimal lifecycle management for drug delivery devices.

Drug Delivery 52

Drug Delivery Engineer Packaging Packaging 52

Roots Analysis

AUGUST 8, 2023

Furthermore, a wide variety of drugs and macromolecules, including DNA , proteins, and imaging agents, can be encapsulated in liposomal vesicles due to their unique ability to entrap both lipophilic and hydrophilic substances. The various therapeutic applications of liposomes in drug delivery have been highlighted in the figure.

Drug Delivery Systems 52

Drug Delivery Systems Drug Delivery Drugs In-Vivo 52

pharmaphorum

SEPTEMBER 22, 2021

Abexxa will form part of its broad push into immuno-oncology, focused on cancer vaccines, oncolytic viruses and T-cell engagers, amongst other treatment strategies. Earlier this year, it backed out of a $600 million alliance with CureVac focused on developed mRNA-based vaccines for cancer. Last December, Boehringer paid €1.8

Antibody 88

Antibody Drug Delivery Vaccination Vaccine 88

Pharmaceutical Technology

JUNE 23, 2022

During the peak of the Covid-19 pandemic this challenge reached new heights, as pharmaceutical firms around the world mobilised the full might of their resources to try and identify, develop, and trial a wide range of vaccines and therapeutics to alleviate the lethal threat posed by the virus. Decentralised trials continue to be in-demand.

Trials 130

Trials Clinical Trials Clinical Trials Drug Delivery 130

pharmaphorum

OCTOBER 18, 2021

The RNA therapeutics industry has grown at an exponential rate in recent years, with an increased spotlight following the industry’s leading role in developing vaccines against COVID-19 in response to the global pandemic. Delve into the latest innovations in novel RNA delivery and target specificity. Hashtag: #SMiRNA.

RNA 52

RNA Drug Delivery Scientist Clinical Development 52

Outsourcing Pharma

AUGUST 3, 2021

The success of mRNA vaccine technology could be one of the new opportunities for US pharmaceutical manufacturing looking forward, with pandemic investments helping turbocharge the sector.

Manufacturing 110

Manufacturing Vaccination Vaccine Drug Delivery 110

Roots Analysis

MARCH 13, 2022

In the last decade alone, the annual number of approvals of biopharmaceuticals (including monoclonal antibodies, recombinant proteins, vaccines and gene therapies), by the US FDA, have steadily risen. Over the years, the rising popularity of biologics has led to a paradigm shift in the healthcare industry. Our Social Media Platform.

Manufacturing 52

Manufacturing Drug Delivery Marketing Drug Delivery Systems 52

pharmaphorum

JANUARY 18, 2022

The past year has seen significant developments in the injectables landscape with the rapid introduction and development of vaccines in response to the pandemic, updates in regulations including the EU MDR and FDA guidance on bridging studies, and increasing industry acceptance of connectivity to aid the user experience. 13.00 – 17.00.

Drug Delivery 52

Drug Delivery Production Drug Delivery Systems Packaging 52

The Pharma Data

JUNE 7, 2023

LNPs are spheric drug delivery bodies which can be equipped with therapeutic payloads for intracellular delivery. Acuitas’ LNP technology will support Bayer’s in vivo gene editing and protein replacement programs by specifically delivering RNA payloads to the desired target organ, the liver.

Gene Therapy 40

Gene Therapy Gene Gene Editing In-Vivo 40

Roots Analysis

MARCH 9, 2022

In the last decade alone, the annual number of approvals of biopharmaceuticals (including monoclonal antibodies, recombinant proteins, vaccines, and gene therapies), by the US FDA, have steadily risen. Over the years, the rising popularity of biologics has led to a paradigm shift in the healthcare industry.

Manufacturing 52

Manufacturing Marketing Contract Manufacturing Protein 52

XTalks

MAY 24, 2023

RELATED: Walgreens, CVS, Amazon and Walmart Compete in Prescription Drug Delivery Factors Behind the CVS Health Clinical Trial Services Closure Speculations are rife in the industry for reasons behind the closure of CVS Health Clinical Trial Services.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Pharmacy 97

Roots Analysis

OCTOBER 5, 2023

Driven by the increasing need for safe and efficient medical devices and drug delivery systems, the pharmaceutical polymers / medical grade polymers domain is advancing significantly. Vaccine Adjuvants: Polymers often serve as carriers for releasing the antigen and thereby regulating the immunological responses.

Manufacturing 40

Manufacturing Drug Delivery Systems Drug Delivery Packaging 40

Roots Analysis

FEBRUARY 18, 2022

Therefore, myeloid therapies have gained significant attention as a potential adjunct to currently used therapies, such as immune checkpoint inhibitors, dendritic cell vaccines, oncolytic viruses, and chemoradiation to enhance therapeutic response. Our Social Media Platform. Web: [link]. LinkedIn: [link]. Twitter: [link]. Medium: [link].

Drug Delivery Systems 52

Drug Delivery Systems Immune Response Clinical Trials Clinical Trials 52

Cloudbyz

MAY 15, 2023

For instance, if the trial involves a novel drug-delivery system, the DSMB might include a pharmaceutical scientist. The Role of DSMB in the COVID-19 Pandemic The importance of DSMBs was highlighted during the COVID-19 pandemic when several vaccines were developed and tested in clinical trials at record speed.

Clinical Trials 69

Clinical Trials Clinical Trials Trials Drug Delivery Systems 69

Roots Analysis

MARCH 16, 2023

In the last few years, researchers have become interested in using in vitro transcribed (IVT) mRNA as a drug delivery agent. It is worth noting that several companies have begun to develop mRNA-based cancer immunotherapies and vaccines for infectious diseases.

Vaccination 52

Vaccination Vaccine DNA Protein 52

Roots Analysis

FEBRUARY 20, 2022

In addition, in order to address the cell boundary challenge associated with the mRNA COVID-19 vaccines, majority of the deals in this industry have been inked for manufacturing lipid nanoparticles, required to envelop and deliver the mRNA (over 55%). Of these, 90% of the partnerships have been inked with industry players. Web: [link].

Contract Manufacturing 52

Contract Manufacturing Bioavailability Manufacturing Drug Delivery Systems 52

The Pharma Data

SEPTEMBER 11, 2020

Starpharma experimenting with Gilead’s antiviral drug for easier administration. Melbourne-based Starpharma has announced it has applied its novel DEP drug delivery technology to create a long ? This week’s round up dives into developments from companies based in Australia and the US. acting, water-soluble version of remdesivir.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

pharmaphorum

DECEMBER 15, 2022

Stefan Woxström is the new senior vice president for Europe and Canada at AstraZeneca, moving over from the company’s Japanese division to take over from Iskra Reic , who will now serve as EVP of vaccines and immune therapies. New CEO in at Angelini Pharma. More CEO shakeups.

Sales 52

Sales In-Vitro Antibody Drug Delivery 52

STAT News

NOVEMBER 3, 2022

… A Delaware federal court refused to throw out patent infringement claims brought by Arbutus Biopharma and Genevant Sciences against Moderna over its sale of Covid-19 vaccine doses to the U.S.  Genevant and Arbutus sued Moderna in February, seeking royalties from Moderna’s sale of its Covid-19 vaccine.

Vaccination 97

Vaccination Vaccine Drug Delivery Systems Sales 97

pharmaphorum

JANUARY 12, 2023

Other than the oral insulin , Oramed is developing an oral formulation of a glucagon-like peptide-1 (GLP-1) analogue called ORMD-0901, but that remains in early clinical development, along with an oral COVID-19 vaccine.

Insulin 59

Insulin Trials Development Drugs 59

pharmaphorum

JANUARY 12, 2021

ImmunityBio has licensed technology underpinning a COVID-19 vaccine that could be administered orally rather than by injection from UK biotech iosBio. Non-injectables remove the need for health professional-led immunisation programmes, making widespread vaccine roll-outs quicker and easier and more affordable,” Channon told pharmaphorum.

Licensing 119

Licensing Licensing Vaccination Vaccine 119

The Pharma Data

MARCH 15, 2022

For the Sarclisa ® subcutaneous formulation delivery, Sanofi has partnered with drug delivery technology innovator company Enable Injections , Inc. to advance the development of a subcutaneous delivery for Sarclisa ® with the goal of offering a unique patient-centric treatment experience.

Life Science 52

Life Science Antibody Clinical Trials Clinical Trials 52